How Much Do You Know About Sjögren’s Disease? — Quiz

YOUR LOGO

How Much Do You Know About Sjögren’s Disease?

8 quick questions • Instant scoring • Short explanations

Sjögren's Quiz

Q1Which glands are most commonly affected in Sjögren’s disease?

Sweat and oil glands Lymph nodes and adrenal glands Salivary and tear glands Pituitary and thyroid glands

Correct: Salivary and tear glands — this causes dry mouth and dry eyes.

Q2What is a serious long-term complication associated with Sjögren’s disease?

Parkinson’s disease Kidney failure Lymphoma Diabetes

Correct: Lymphoma — Sjögren's increases lymphoma risk for some patients.

Q3What percentage of Sjögren’s patients are women?

60 percent 70 percent 80 percent 90 percent

Correct: About 90% — the condition predominantly affects women.

Q4Which of the following is NOT a common extraglandular symptom of Sjögren’s?

Muscle pain Dry, persistent cough Seizures Gastrointestinal issues

Correct: Seizures are not commonly listed; other neurologic symptoms like numbness/dizziness may occur.

Q5Why is Sjögren’s often difficult to diagnose?

It only appears in lab tests, not through symptoms. Its symptoms are dramatic and rapid. It evolves slowly and its early symptoms are common and mild. There are no reliable diagnostic tools.

Correct: It evolves slowly and early signs can be mild or nonspecific, which delays diagnosis.

Q6What was Sjögren’s disease previously called?

Sjögren’s lymphoma Sicca complex syndrome or Mikulicz’s disease Autoimmune tear gland disorder Ocular dryness syndrome

Correct: Sicca complex or Mikulicz’s disease were historical names.

Q7What may be the likely cause of Sjögren’s, according to current understanding?

Viral infection alone Hormonal imbalance Genetic predisposition triggered by environmental factors Vitamin deficiency

Correct: A combination of genetic predisposition and environmental triggers is likely.

Q8What recent drug has received FDA breakthrough therapy designation for Sjögren’s?

Prednisone Rituximab Nipocalimab Methotrexate

Correct: Nipocalimab has received attention with breakthrough designation in recent years.

Progress: 0/8

Designed for readability and SEO — includes JSON-LD FAQ schema and on-page scoring. Color theme: deep green + white. Accessible (ARIA) and mobile responsive.